HAEMOPHILUS PARASUIS VACCINE SEROVAR TYPE FOUR
    2.
    发明申请
    HAEMOPHILUS PARASUIS VACCINE SEROVAR TYPE FOUR 有权
    HAEMOPHILUS PARASUIS VACCINE SEROVAR TYPE四

    公开(公告)号:US20150098968A1

    公开(公告)日:2015-04-09

    申请号:US14507397

    申请日:2014-10-06

    申请人: MERIAL LIMITED

    IPC分类号: A61K39/102

    摘要: The present invention is a Haemophilus parasuis vaccine against serovar type 4 capable of triggering a protective immune response when administered to pigs as a killed vaccine. The present invention is also a method for vaccinating swine against Haemophilus parasuis infection, serovar type 4, by a) clonally propagating one or more cells which are capable of triggering an immune response against Haemophilus parasuis infection, serovar type 4, that protects the pig against Haemophilus parasuis infection, and b) combining an immunologically effective amount of the cells with a veterinarily acceptable carrier in a form suitable for administration as a vaccine to the pig, and c) administering as a killed vaccine. The cell culture is from a pathogenic parent strain.

    摘要翻译: 本发明是针对血清型4型的嗜血杆菌疫苗,当作为杀死的疫苗施用于猪时,能够引发保护性免疫应答。 本发明还是一种通过以下方式,一种用于接种针对嗜血杆菌的副嗜血杆菌感染(4型血清型)的方法:a)克隆扩增一种或多种能够引发针对嗜血杆菌副嗜血杆菌感染的免疫应答的细胞,其可以保护猪免于 嗜血杆菌副嗜血杆菌感染,以及b)将免疫有效量的细胞与兽医学上可接受的载体以适合作为疫苗施用于猪的形式组合,以及c)作为灭活疫苗施用。 细胞培养来自病原性亲本菌株。

    Haemophilus parasuis vaccine serovar type four
    3.
    发明授权
    Haemophilus parasuis vaccine serovar type four 有权
    嗜血杆菌疫苗血清型4型

    公开(公告)号:US09504740B2

    公开(公告)日:2016-11-29

    申请号:US14507397

    申请日:2014-10-06

    申请人: MERIAL LIMITED

    IPC分类号: A61K39/102 A61K39/00

    摘要: The present invention is a Haemophilus parasuis vaccine against serovar type 4 capable of triggering a protective immune response when administered to pigs as a killed vaccine. The present invention is also a method for vaccinating swine against Haemophilus parasuis infection, serovar type 4, by a) clonally propagating one or more cells which are capable of triggering an immune response against Haemophilus parasuis infection, serovar type 4, that protects the pig against Haemophilus parasuis infection, and b) combining an immunologically effective amount of the cells with a veterinarily acceptable carrier in a form suitable for administration as a vaccine to the pig, and c) administering as a killed vaccine. The cell culture is from a pathogenic parent strain.

    摘要翻译: 本发明是针对血清型4型的嗜血杆菌疫苗,当作为杀死的疫苗施用于猪时,能够引发保护性免疫应答。 本发明还是一种通过以下方式,一种用于接种针对嗜血杆菌的副嗜血杆菌感染(4型血清型)的方法:a)克隆扩增一种或多种能够引发针对嗜血杆菌副嗜血杆菌感染的免疫应答的细胞,其可以保护猪免于 嗜血杆菌副嗜血杆菌感染,以及b)将免疫有效量的细胞与兽医学上可接受的载体以适合作为疫苗施用于猪的形式组合,以及c)作为灭活疫苗施用。 细胞培养来自病原性亲本菌株。